 | Up a level |
Dinges, S; Morard, I; Heim, M; Dufour, Jean-François; Müllhaupt, B; Giostra, E; Clavien, P-A; Mentha, G; Negro, F (2009). Pegylated interferon-alpha2a/ribavirin treatment of recurrent hepatitis C after liver transplantation. Transplant infectious disease, 11(1), pp. 33-9. Hoboken, N.J.: Wiley 10.1111/j.1399-3062.2008.00359.x
Helbling, B; Jochum, W; Stamenic, I; Knöpfli, M; Cerny, A; Borovicka, J; Gonvers, JJ; Wilhelmi, M; Dinges, S; Müllhaupt, B; Esteban, A; Meyer-Wyss, B; Renner, EL; Swiss, Association for the Study of the Liver (SASL) (2006). HCV-related advanced fibrosis/cirrhosis: randomized controlled trial of pegylated interferon alpha-2a and ribavirin. Journal of viral hepatitis, 13(11), pp. 762-9. Oxford: Blackwell Science 10.1111/j.1365-2893.2006.00753.x
